Medical Device Research & Development · Now Enrolling

Breast Ultrasound Prospective Case Study

Help shape the future of women's breast health

Aperia Medical is advancing how breast tissue is detected and analyzed — using AI-powered ultrasound technology to improve early identification of potential health concerns. Your participation matters.

See if you qualify Learn about the study →
Compensation provided
Patient undergoing ATBUS scan
Technology
ATBUS · FDA PMA-approved
No radiation · Non-invasive

About the study

Technology built for clearer answers

The Automated Tomographic Breast Ultrasound (ATBUS) Prospective Clinical Case Collection (PCC) study collects imaging data to improve how ultrasound technology captures, processes, and interprets breast tissue — helping clinicians detect potential problem areas with greater confidence and precision.

📸
Clearer image capture
Enhanced ultrasound acquisition for sharper, more detailed breast imaging.
🖥
Advanced image processing
Improved algorithms that refine raw scan data into high-resolution diagnostic images.
🤖
AI-powered tissue analysis
Machine learning tools trained to identify tissue types and flag areas of clinical interest.
ATBUS system with technician
ATBUS scanner close-up
ATBUS system

Eligibility

Do you qualify?

If you are a woman and meet the following criteria, we want to hear from you. Your participation may help drive technology advancements that improve breast cancer detection for women in the future.

Eligibility criteria

You must meet all of the following requirements to participate in this research study.

Compensation provided for your time and participation
✓
Recommended for an ultrasound-guided breast biopsy
✓
Age 18 or older, weigh 350 lbs or less, and no taller than 6 ft 6 in (198 cm)
✓
Agree to be scanned at Aperia's offices in Livonia and release relevant medical information
✓
Can lie on your stomach on the exam table for up to 30 minutes and willing to provide written informed consent
✓
Do not have symptoms of scabbing, cracking, peeling, scaling, open sores, weeping rashes, or bleeding affecting the chest area of the body

Call or email us for more information

☎
(408) 607-7892 Mon – Fri, business hours
✉
research@aperiamedical.com We respond within 2 business days

Check your eligibility

Complete the form and our team will be in touch within 2 business days.

Your information is kept confidential and used only to determine eligibility. By submitting you agree to be contacted by Aperia Medical's research team.

About Aperia Medical

Advancing breast health through AI-powered imaging

Aperia Medical is working to improve ATBUS technology by making image capturing clearer, processing the images better, and using AI-powered tools to identify different types of tissue and spot potential problem areas.

Aperia Medical is advancing breast imaging technology within an FDA PMA-approved ATBUS platform originally approved in 2021, using enhanced imaging workflows and AI-powered analysis tools to improve breast tissue detection and characterization.